Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis, Phase IIa Clinical Study

Trial Profile

Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis, Phase IIa Clinical Study

Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2017

At a glance

  • Drugs P 03277 (Primary)
  • Indications Liver cirrhosis; Liver disorders
  • Focus Diagnostic use; Proof of concept
  • Sponsors Guerbet
  • Most Recent Events

    • 28 Nov 2017 Planned End Date changed from 1 Aug 2017 to 1 Sep 2018.
    • 28 Nov 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Sep 2018.
    • 03 Jan 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top